Global C1ql2 PAb Market Growth 2024-2030

Publication ID:

LPI08248540

Publication Date:

August 13, 2024

Pages:

144

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

C1q-like protein 2 (C1qL2) polyclonal antibody is a specific antibody mixture against C1q-like protein 2 (C1qL2). C1qL2 is a 287-amino acid secretory protein containing a C1q domain and a collagen-like domain. It belongs to a large multimeric protein family whose globular domains are highly homologous to C1QA and structurally similar to TNF family members. The C1qL2 gene is located on human chromosome 2q14.2, and the gene encoding the protein contains about 2653 base pairs. C1q-like protein 2 polyclonal antibody refers to a mixture of antibodies against different antigenic epitopes of C1qL2 obtained by separation and purification from the serum of immunized animals after immunizing animals with C1q-like protein 2 (C1qL2) or its related antigens. This antibody mixture has a wide range of applications in biomedical research, such as detecting the expression level of C1qL2 protein, studying the biological function of C1qL2, and exploring the relationship between C1qL2 and related diseases.
The global C1ql2 PAb market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淐1ql2 PAb Industry Forecast鈥� looks at past sales and reviews total world C1ql2 PAb sales in 2023, providing a comprehensive analysis by region and market sector of projected C1ql2 PAb sales for 2024 through 2030. With C1ql2 PAb sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world C1ql2 PAb industry.
This Insight Report provides a comprehensive analysis of the global C1ql2 PAb landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on C1ql2 PAb portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global C1ql2 PAb market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for C1ql2 PAb and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global C1ql2 PAb.
United States market for C1ql2 PAb is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for C1ql2 PAb is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for C1ql2 PAb is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key C1ql2 PAb players cover Nittobo, Thermo Fisher Scientific, GeneTex, Abcam, Merck Millipore, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of C1ql2 PAb market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Rabbit Antibody
Other
Segmentation by Application:
Biomedical Research
Drug Development
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Nittobo
Thermo Fisher Scientific
GeneTex
Abcam
Merck Millipore
Santa Cruz Biotechnology
Proteintech
Novus Biologicals
Boster Bio
Bio-Rad Laboratories
Shenzhen Xinbosheng Biotechnology
Shanghai Binzhi Biotechnology
Nanjing Beiyu Biotechnology
Shanghai Xige Biotechnology
Aibixin (Shanghai) Biotechnology
Shanghai Shenger Biotechnology
Guangzhou Weijia Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global C1ql2 PAb market?
What factors are driving C1ql2 PAb market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do C1ql2 PAb market opportunities vary by end market size?
How does C1ql2 PAb break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global C1ql2 PAb Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for C1ql2 PAb by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for C1ql2 PAb by Country/Region, 2019, 2023 & 2030
2.2 C1ql2 PAb Segment by Type
2.2.1 Rabbit Antibody
2.2.2 Other
2.3 C1ql2 PAb Sales by Type
2.3.1 Global C1ql2 PAb Sales Market Share by Type (2019-2024)
2.3.2 Global C1ql2 PAb Revenue and Market Share by Type (2019-2024)
2.3.3 Global C1ql2 PAb Sale Price by Type (2019-2024)
2.4 C1ql2 PAb Segment by Application
2.4.1 Biomedical Research
2.4.2 Drug Development
2.4.3 Other
2.5 C1ql2 PAb Sales by Application
2.5.1 Global C1ql2 PAb Sale Market Share by Application (2019-2024)
2.5.2 Global C1ql2 PAb Revenue and Market Share by Application (2019-2024)
2.5.3 Global C1ql2 PAb Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global C1ql2 PAb Breakdown Data by Company
3.1.1 Global C1ql2 PAb Annual Sales by Company (2019-2024)
3.1.2 Global C1ql2 PAb Sales Market Share by Company (2019-2024)
3.2 Global C1ql2 PAb Annual Revenue by Company (2019-2024)
3.2.1 Global C1ql2 PAb Revenue by Company (2019-2024)
3.2.2 Global C1ql2 PAb Revenue Market Share by Company (2019-2024)
3.3 Global C1ql2 PAb Sale Price by Company
3.4 Key Manufacturers C1ql2 PAb Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers C1ql2 PAb Product Location Distribution
3.4.2 Players C1ql2 PAb Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for C1ql2 PAb by Geographic Region
4.1 World Historic C1ql2 PAb Market Size by Geographic Region (2019-2024)
4.1.1 Global C1ql2 PAb Annual Sales by Geographic Region (2019-2024)
4.1.2 Global C1ql2 PAb Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic C1ql2 PAb Market Size by Country/Region (2019-2024)
4.2.1 Global C1ql2 PAb Annual Sales by Country/Region (2019-2024)
4.2.2 Global C1ql2 PAb Annual Revenue by Country/Region (2019-2024)
4.3 Americas C1ql2 PAb Sales Growth
4.4 APAC C1ql2 PAb Sales Growth
4.5 Europe C1ql2 PAb Sales Growth
4.6 Middle East & Africa C1ql2 PAb Sales Growth
5 Americas
5.1 Americas C1ql2 PAb Sales by Country
5.1.1 Americas C1ql2 PAb Sales by Country (2019-2024)
5.1.2 Americas C1ql2 PAb Revenue by Country (2019-2024)
5.2 Americas C1ql2 PAb Sales by Type (2019-2024)
5.3 Americas C1ql2 PAb Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC C1ql2 PAb Sales by Region
6.1.1 APAC C1ql2 PAb Sales by Region (2019-2024)
6.1.2 APAC C1ql2 PAb Revenue by Region (2019-2024)
6.2 APAC C1ql2 PAb Sales by Type (2019-2024)
6.3 APAC C1ql2 PAb Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe C1ql2 PAb by Country
7.1.1 Europe C1ql2 PAb Sales by Country (2019-2024)
7.1.2 Europe C1ql2 PAb Revenue by Country (2019-2024)
7.2 Europe C1ql2 PAb Sales by Type (2019-2024)
7.3 Europe C1ql2 PAb Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa C1ql2 PAb by Country
8.1.1 Middle East & Africa C1ql2 PAb Sales by Country (2019-2024)
8.1.2 Middle East & Africa C1ql2 PAb Revenue by Country (2019-2024)
8.2 Middle East & Africa C1ql2 PAb Sales by Type (2019-2024)
8.3 Middle East & Africa C1ql2 PAb Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of C1ql2 PAb
10.3 Manufacturing Process Analysis of C1ql2 PAb
10.4 Industry Chain Structure of C1ql2 PAb
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 C1ql2 PAb Distributors
11.3 C1ql2 PAb Customer
12 World Forecast Review for C1ql2 PAb by Geographic Region
12.1 Global C1ql2 PAb Market Size Forecast by Region
12.1.1 Global C1ql2 PAb Forecast by Region (2025-2030)
12.1.2 Global C1ql2 PAb Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global C1ql2 PAb Forecast by Type (2025-2030)
12.7 Global C1ql2 PAb Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Nittobo
13.1.1 Nittobo Company Information
13.1.2 Nittobo C1ql2 PAb Product Portfolios and Specifications
13.1.3 Nittobo C1ql2 PAb Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Nittobo Main Business Overview
13.1.5 Nittobo Latest Developments
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Information
13.2.2 Thermo Fisher Scientific C1ql2 PAb Product Portfolios and Specifications
13.2.3 Thermo Fisher Scientific C1ql2 PAb Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Thermo Fisher Scientific Main Business Overview
13.2.5 Thermo Fisher Scientific Latest Developments
13.3 GeneTex
13.3.1 GeneTex Company Information
13.3.2 GeneTex C1ql2 PAb Product Portfolios and Specifications
13.3.3 GeneTex C1ql2 PAb Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 GeneTex Main Business Overview
13.3.5 GeneTex Latest Developments
13.4 Abcam
13.4.1 Abcam Company Information
13.4.2 Abcam C1ql2 PAb Product Portfolios and Specifications
13.4.3 Abcam C1ql2 PAb Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Abcam Main Business Overview
13.4.5 Abcam Latest Developments
13.5 Merck Millipore
13.5.1 Merck Millipore Company Information
13.5.2 Merck Millipore C1ql2 PAb Product Portfolios and Specifications
13.5.3 Merck Millipore C1ql2 PAb Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Merck Millipore Main Business Overview
13.5.5 Merck Millipore Latest Developments
13.6 Santa Cruz Biotechnology
13.6.1 Santa Cruz Biotechnology Company Information
13.6.2 Santa Cruz Biotechnology C1ql2 PAb Product Portfolios and Specifications
13.6.3 Santa Cruz Biotechnology C1ql2 PAb Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Santa Cruz Biotechnology Main Business Overview
13.6.5 Santa Cruz Biotechnology Latest Developments
13.7 Proteintech
13.7.1 Proteintech Company Information
13.7.2 Proteintech C1ql2 PAb Product Portfolios and Specifications
13.7.3 Proteintech C1ql2 PAb Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Proteintech Main Business Overview
13.7.5 Proteintech Latest Developments
13.8 Novus Biologicals
13.8.1 Novus Biologicals Company Information
13.8.2 Novus Biologicals C1ql2 PAb Product Portfolios and Specifications
13.8.3 Novus Biologicals C1ql2 PAb Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Novus Biologicals Main Business Overview
13.8.5 Novus Biologicals Latest Developments
13.9 Boster Bio
13.9.1 Boster Bio Company Information
13.9.2 Boster Bio C1ql2 PAb Product Portfolios and Specifications
13.9.3 Boster Bio C1ql2 PAb Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Boster Bio Main Business Overview
13.9.5 Boster Bio Latest Developments
13.10 Bio-Rad Laboratories
13.10.1 Bio-Rad Laboratories Company Information
13.10.2 Bio-Rad Laboratories C1ql2 PAb Product Portfolios and Specifications
13.10.3 Bio-Rad Laboratories C1ql2 PAb Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Bio-Rad Laboratories Main Business Overview
13.10.5 Bio-Rad Laboratories Latest Developments
13.11 Shenzhen Xinbosheng Biotechnology
13.11.1 Shenzhen Xinbosheng Biotechnology Company Information
13.11.2 Shenzhen Xinbosheng Biotechnology C1ql2 PAb Product Portfolios and Specifications
13.11.3 Shenzhen Xinbosheng Biotechnology C1ql2 PAb Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Shenzhen Xinbosheng Biotechnology Main Business Overview
13.11.5 Shenzhen Xinbosheng Biotechnology Latest Developments
13.12 Shanghai Binzhi Biotechnology
13.12.1 Shanghai Binzhi Biotechnology Company Information
13.12.2 Shanghai Binzhi Biotechnology C1ql2 PAb Product Portfolios and Specifications
13.12.3 Shanghai Binzhi Biotechnology C1ql2 PAb Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Shanghai Binzhi Biotechnology Main Business Overview
13.12.5 Shanghai Binzhi Biotechnology Latest Developments
13.13 Nanjing Beiyu Biotechnology
13.13.1 Nanjing Beiyu Biotechnology Company Information
13.13.2 Nanjing Beiyu Biotechnology C1ql2 PAb Product Portfolios and Specifications
13.13.3 Nanjing Beiyu Biotechnology C1ql2 PAb Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Nanjing Beiyu Biotechnology Main Business Overview
13.13.5 Nanjing Beiyu Biotechnology Latest Developments
13.14 Shanghai Xige Biotechnology
13.14.1 Shanghai Xige Biotechnology Company Information
13.14.2 Shanghai Xige Biotechnology C1ql2 PAb Product Portfolios and Specifications
13.14.3 Shanghai Xige Biotechnology C1ql2 PAb Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Shanghai Xige Biotechnology Main Business Overview
13.14.5 Shanghai Xige Biotechnology Latest Developments
13.15 Aibixin (Shanghai) Biotechnology
13.15.1 Aibixin (Shanghai) Biotechnology Company Information
13.15.2 Aibixin (Shanghai) Biotechnology C1ql2 PAb Product Portfolios and Specifications
13.15.3 Aibixin (Shanghai) Biotechnology C1ql2 PAb Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Aibixin (Shanghai) Biotechnology Main Business Overview
13.15.5 Aibixin (Shanghai) Biotechnology Latest Developments
13.16 Shanghai Shenger Biotechnology
13.16.1 Shanghai Shenger Biotechnology Company Information
13.16.2 Shanghai Shenger Biotechnology C1ql2 PAb Product Portfolios and Specifications
13.16.3 Shanghai Shenger Biotechnology C1ql2 PAb Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Shanghai Shenger Biotechnology Main Business Overview
13.16.5 Shanghai Shenger Biotechnology Latest Developments
13.17 Guangzhou Weijia Technology
13.17.1 Guangzhou Weijia Technology Company Information
13.17.2 Guangzhou Weijia Technology C1ql2 PAb Product Portfolios and Specifications
13.17.3 Guangzhou Weijia Technology C1ql2 PAb Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Guangzhou Weijia Technology Main Business Overview
13.17.5 Guangzhou Weijia Technology Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂